SavedAdd your journal

Journals / Mustafa Kemal Üniversitesi Tıp Dergisi / 2021 / Cilt: 12 - Sayı: 43

Relationship Between Diabetic Peripheral Neuropathy and Vitamin D

Diyabetik Periferik Nöropati ve Vitamin D İlişkisi

İzzet BİNGÖL
Alper UYSAL
Pages
100–105
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When DPN subgroups were compared within themselves, diabetes duration and HbA1c levels were found to be statistically significantly higher in the electrophysiologically supported DPN group.Conclusion: Low vitamin D levels can accelerate the development of neuropathy in diabetic patients and worsen the clinical picture of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to compare electrophysiologically supported and unsupported diabetic peripheral neuropathy (DPN) patients in terms of vitamin D levels within themselves and with the control group.Methods: Patients who applied to Hatay State Hospital Physical Medicine and Rehabilitation Outpatient Clinic and were diagnosed with DPN were divided into two groups according to whether or not pathological findings were detected electrophysiologically.
📊
Key Findings & Data:DPN subgroups were also compared in terms of HbA1c levels and duration of diabetes.Results: No statistically significant difference was found between the DPN groups and the control group in terms of age and gender.
💡
Conclusion & Impact:When DPN subgroups were compared within themselves, diabetes duration and HbA1c levels were found to be statistically significantly higher in the electrophysiologically supported DPN group.Conclusion: Low vitamin D levels can accelerate the development of neuropathy in diabetic patients and worsen the clinical picture of patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diyabetik periferik nöropati · D vitamini · Elektromiyografi

Abstract

Objective: We aimed to compare electrophysiologically supported and unsupported diabetic peripheral neuropathy (DPN) patients in terms of vitamin D levels within themselves and with the control group.Methods: Patients who applied to Hatay State Hospital Physical Medicine and Rehabilitation Outpatient Clinic and were diagnosed with DPN were divided into two groups according to whether or not pathological findings were detected electrophysiologically. Patients of similar age and gender, who applied to the outpatient clinic with complaints of muscle pain, formed the control group and the groups were compared in terms of vitamin D levels. DPN subgroups were also compared in terms of HbA1c levels and duration of diabetes.Results: No statistically significant difference was found between the DPN groups and the control group in terms of age and gender. Vitamin D levels were found to be significantly higher in the control group compared to the electrophysiologically supported DPN group. When DPN subgroups were compared within themselves, diabetes duration and HbA1c levels were found to be statistically significantly higher in the electrophysiologically supported DPN group.Conclusion: Low vitamin D levels can accelerate the development of neuropathy in diabetic patients and worsen the clinical picture of patients.

Özet

Amaç: Elektrofizyolojik olarak desteklenen ve desteklenmeyen diyabetik periferik nöropati (DPN) hastalarının, kendi içerisinde ve kontrol grubu ile D vitamini düzeyleri açısından karşılaştırması amaçlanmıştır.Yöntem: Hatay Devlet Hastanesi Fiziksel Tıp ve Rehabilitasyon Polikliniğine başvurmuş ve DPN tanısı almış hastalar elektrofizyolojik olarak patolojik bulgu saptanıp, saptanmamalarına göre iki gruba ayrıldı. Benzer yaş ve cinsiyette, kas ağrısı şikâyeti ile poliklinik başvurusu olan hastalar da kontrol grubunu oluşturdu ve gruplar D vitamini düzeyleri açısından karşılaştırıldı. DPN alt grupları da kendi içerisinde HbA1c seviyeleri ve diyabet süreleri açısından kıyaslandı.Bulgular: DPN grupları ve kontrol grubu arasında yaş ve cinsiyet açısından istatistiksel olarak anlamlı farklılık saptanmadı. Vitamin D düzeyleri, elektrofizyolojik olarak desteklenen DPN grubuna kıyasla, kontrol grubunda anlamlı derecede daha yüksek bulunmuştur. DPN alt grupları kendi içerisinde karşılaştırıldığında elektrofizyolojik olarak desteklenen DPN grubunda, diyabet süresi ve HbA1c düzeyleri istatistiksel olarak anlamlı olacak şekilde daha yüksek bulunmuştur.Sonuç: Düşük D vitamini seviyeleri diyabetik hastalarda nöropati gelişimini hızlandırabilir ve hastaların klinik durumlarını kötüleştirebilir.

🔖

Cite This Article

BİNGÖL, İ., UYSAL, A. (2021). Relationship Between Diabetic Peripheral Neuropathy and Vitamin D. Mustafa Kemal Üniversitesi Tıp Dergisi, Cilt: 12 - Sayı: 43, 100–105. https://ajindex.com/articles/288508

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol, 2012. 11(6): p. 521-34. https://doi.org/10.1016/S1474-4422(12)70065-0
  2. Sari A, Akdoğan AZ, Arifoglu KC, Bilir KB, Durmus B. Does Vitamin D Affect Diabetic Neuropathic Pain and Balance? J Pain Res, 2020. 13: p. 171-179. https://doi.org/10.2147/JPR.S203176
  3. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther, 2008. 120(1): p. 1-34. https://doi.org/10.1016/j.pharmthera.2008.05.005
  4. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract, 2010. 64(3): p. 351-5. https://doi.org/10.1111/j.1742-1241.2009.02221.x
  5. Usluogullari CA, Balkan F, Caner S, Ucler R, Kaya C, Ersoy R, et al. The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus. BMC Endocr Disord, 2015. 15(33): p. 015-0029. https://doi.org/10.1186/s12902-015-0029-y
  6. Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N. Vitamin D deficiency and peripheral diabetic neuropathy: Eur J Intern Med. 2012 Mar;23(2):e67-8. Epub 2011 Dec 10. https://doi.org/10.1016/j.ejim.2011.11.008
  7. Lee JI, Oh SJ, Ha WC, Kwon HS, Sohn TS, Son HS, et al. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res Clin Pract, 2012. 95(1): p. 42-7. https://doi.org/10.1016/j.diabres.2011.09.006
  8. Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N, et al. Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment. Endocr J, 2006. 53(4): p. 503-10. https://doi.org/10.1507/endocrj.K06-001
  9. Al-Timimi, D.J. and A.F. Ali, Serum 25(OH) D in Diabetes Mellitus Type 2: Relation to Glycaemic Control. J Clin Diagn Res, 2013. 7(12): p. 2686-8. https://doi.org/10.7860/JCDR/2013/6712.3733
  10. Olt, S. Relationship between vitamin D and glycemic control in patients with type 2 diabetes mellitus. Int J Clin Exp Med, 2015. 8(10): p. 19180-3.
  11. Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, Nakamichi N, et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res, 2006. 83(7): p. 1179-89. https://doi.org/10.1002/jnr.20824
  12. Chabas JF, Stephan D, Marqueste T, Garcia S, Lavaut